David Hamel

Modulation of immune cell reactivity with cis -binding Siglec agonists

Retinopathy of prematurity

Trends in GPCR drug discovery: new agents, targets and indications

Inflammaging: a new immune–metabolic viewpoint for age-related diseases

Role of the Microbiota in Immunity and Inflammation

Cellular senescence in ageing: from mechanisms to therapeutic opportunities

Neovascularization in retinopathy of prematurity: opposing actions of neuronal factors GPR91 and semaphorins 3A

Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye

Semaphorin 3F forms an anti‐angiogenic barrier in outer retina

Innate Immune Function by Toll-like Receptors: Distinct Responses in Newborns and the Elderly

Understanding Retinopathy of Prematurity: Update on Pathogenesis

Defining trained immunity and its role in health and disease

VEGF in Signaling and Disease: Beyond Discovery and Development

Immunobiography and the Heterogeneity of Immune Responses in the Elderly: A Focus on Inflammaging and Trained Immunity

Modulation of three key innate immune pathways for the most common retinal degenerative diseases

GPR40 agonists for the treatment of type 2 diabetes: life after ‘TAKing’ a hit

Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy

Tissue-specific contributions of Tmem79 to atopic dermatitis and mast cell-mediated histaminergic itch

5-Lipoxygenase Metabolite 4-HDHA Is a Mediator of the Antiangiogenic Effect of ω-3 Polyunsaturated Fatty Acids

Expansions of NK-like αβT cells with chronologic aging: Novel lymphocyte effectors that compensate for functional deficits of conventional NK cells and T cells

Proliferative retinopathies: Angiogenesis that blinds

NK-Like T Cells and Plasma Cytokines, but Not Anti-Viral Serology, Define Immune Fingerprints of Resilience and Mild Disability in Exceptional Aging

Fatty Acid Receptor Gpr40 Mediates Neuromicrovascular Degeneration Induced by Transarachidonic Acids in Rodents

Microglia and Interleukin-1β in Ischemic Retinopathy Elicit Microvascular Degeneration Through Neuronal Semaphorin-3A